MBT Munich Biotechnology GMBH
This article was originally published in Start Up
Executive Summary
MBT Munich Biotechnology is developing cancer diagnostics and therapeutics that it hopes will allow early tumor detection along with localized, lower-dose and safe cancer treatments. Its technology is based on the encapsulation of different compounds into positively charged liposomes that it calls "catioms."